These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17944584

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sevelamer carbonate.
    Barna MM, Kapoian T, O'Mara NB.
    Ann Pharmacother; 2010 Jan; 44(1):127-34. PubMed ID: 19955298
    [Abstract] [Full Text] [Related]

  • 25. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N, Amor J, Cambil T, Salgueira M, Sánchez-Palencia R, Páez C, Gómez O, Palma A.
    Nefrologia; 2003 Jan; 23 Suppl 2():64-8. PubMed ID: 12778857
    [Abstract] [Full Text] [Related]

  • 26. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
    Koiwa F, Onoda N, Kato H, Tokumoto A, Okada T, Fukagawa M, Shigematsu T, ROD 21 Clinical Research Group.
    Ther Apher Dial; 2005 Aug; 9(4):340-6. PubMed ID: 16076379
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis—sevelamer hydrochloride, calcium carbonate, and bixalomer.
    Sanai T, Tada H, Ono T, Fukumitsu T.
    Hemodial Int; 2015 Jan; 19(1):54-9. PubMed ID: 24980286
    [Abstract] [Full Text] [Related]

  • 34. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
    Noto L.
    J Ren Nutr; 2011 May; 21(3):277-82. PubMed ID: 20598905
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
    Mydlík M, Derzsiová K, Pribylincová V, Reznícek J.
    Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    Di Iorio B, Bellasi A, Russo D, INDEPENDENT Study Investigators.
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):487-93. PubMed ID: 22241819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.